Initiator Pharma A/S publishes information memorandum in connection with the change of listing to Nasdaq First North Growth Markets
On Monday October 7, 2021 Nasdaq Stockholm AB approved Initiator Pharma A/S (“Initiator Pharma” or the “Company”) application for admission to trading of the Company’s shares on Nasdaq First North Growth Markets in Stockholm. Today, the Company publishes an information memorandum, in accordance with Nasdaq First North Growth Markets rules for application.The memorandum is available as attached pdf file and on the Company’s website https://initiatorpharma.com/investors/. The memorandum is not a prospectus, has not been approved by the Danish Financial Supervisory Authority (Dk.